These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 3012393)
41. Pharmacology of DuP 532, a selective and noncompetitive AT1 receptor antagonist. Wong PC; Hart SD; Chiu AT; Herblin WF; Carini DJ; Smith RD; Wexler RR; Timmermans PB J Pharmacol Exp Ther; 1991 Nov; 259(2):861-70. PubMed ID: 1941632 [TBL] [Abstract][Full Text] [Related]
42. Organ specificity of angiotensin II and Des-aspartyl angiotensin II in the conscious rat. Campbell WB; Pettinger WA J Pharmacol Exp Ther; 1976 Aug; 198(2):450-6. PubMed ID: 948036 [TBL] [Abstract][Full Text] [Related]
43. Evidence for agonist-induced interaction of angiotensin receptor with a guanine nucleotide-binding protein in bovine adrenal zona glomerulosa. De Léan A; Ong H; Gutkowska J; Schiller PW; McNicoll N Mol Pharmacol; 1984 Nov; 26(3):498-508. PubMed ID: 6092899 [TBL] [Abstract][Full Text] [Related]
44. Ovariectomy permits progesterone to increase the binding of [3H]spiperone to the anterior pituitary gland in estrogen-primed rats. Pilotte NS; Burt DR; Barraclough CA Endocrinology; 1989 Feb; 124(2):805-11. PubMed ID: 2912702 [TBL] [Abstract][Full Text] [Related]
45. Abnormal adrenal responsiveness and angiotensin II dependency in high renin essential hypertension. Dluhy RG; Bavli SZ; Leung FK; Solomon HS; Moore TJ; Hollenberg NK; Williams GH J Clin Invest; 1979 Nov; 64(5):1270-6. PubMed ID: 500810 [TBL] [Abstract][Full Text] [Related]
46. Dopamine receptor reappearance after irreversible receptor blockade: effect of chronic estradiol treatment of ovariectomized rats. Lévesque D; Di Paolo T Mol Pharmacol; 1991 May; 39(5):659-65. PubMed ID: 1674586 [TBL] [Abstract][Full Text] [Related]
47. Angiotensin II and aldosterone receptor binding in rat heart and kidney: response to chronic angiotensin II or aldosterone administration. Sun Y; Weber KT J Lab Clin Med; 1993 Oct; 122(4):404-11. PubMed ID: 8228554 [TBL] [Abstract][Full Text] [Related]
48. Fate of [125I]angiotensin II in adrenal zona glomerulosa cells. Bianchi C; Gutkowska J; De Léan A; Ballak M; Anand-Srivastava MB; Genest J; Cantin M Endocrinology; 1986 Jun; 118(6):2605-7. PubMed ID: 2870918 [TBL] [Abstract][Full Text] [Related]
49. Quantitative autoradiographic characterization of receptors for angiotensin II and other neuropeptides in individual brain nuclei and peripheral tissues from single rats. Israel A; Plunkett LM; Saavedra JM Cell Mol Neurobiol; 1985 Sep; 5(3):211-22. PubMed ID: 2998623 [TBL] [Abstract][Full Text] [Related]
50. Characterization of bovine ovary angiotensin II receptors using subtype-selective antagonists. Aiyar N; Griffin E; Edwards R; Weinstock J; Samanen J; Nambi P Pharmacology; 1993; 46(1):1-8. PubMed ID: 8434027 [TBL] [Abstract][Full Text] [Related]
51. Selective reduction of adrenal medulla response to angiotensin induced by suppression of renin-angiotensin. Mazur-Ruder M; Feuerstein G; Roll D; Gutman Y Eur J Pharmacol; 1979 Nov; 59(3-4):261-6. PubMed ID: 393522 [TBL] [Abstract][Full Text] [Related]
52. Antihypertensive mechanism of captopril in renal hypertensive rats: studies with a nonpeptide angiotensin II receptor antagonist and an angiotensin II monoclonal antibody. Wong PC; Price WA; Reilly TM; Duncia JV; Timmermans PB J Pharmacol Exp Ther; 1989 Aug; 250(2):515-22. PubMed ID: 2668502 [TBL] [Abstract][Full Text] [Related]
54. Ovarian steroids modulate the release of dopamine into hypophysial portal blood and the density of anterior pituitary [3H]spiperone-binding sites in ovariectomized rats. Pilotte NS; Burt DR; Barraclough CA Endocrinology; 1984 Jun; 114(6):2306-11. PubMed ID: 6723585 [TBL] [Abstract][Full Text] [Related]
55. Effect of angiotensin II and deoxycorticosterone infusion on vascular angiotensin II receptors in rats. Schiffrin EL; Gutkowska J; Genest J Am J Physiol; 1984 Apr; 246(4 Pt 2):H608-14. PubMed ID: 6326599 [TBL] [Abstract][Full Text] [Related]
56. Pharmacological profile of a highly potent and long-acting angiotensin II receptor antagonist, 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4- yl]methyl]-1H-benzimidazole-7-carboxylic acid (CV-11974), and its prodrug, (+/-)-1-(cyclohexyloxycarbonyloxy)-ethyl 2-ethoxy-1-[[2'-(1H-tetrazol-5- yl)biphenyl-4-yl]methyl]-1H-benzimidazole-7-carboxylate (TCV-116). Shibouta Y; Inada Y; Ojima M; Wada T; Noda M; Sanada T; Kubo K; Kohara Y; Naka T; Nishikawa K J Pharmacol Exp Ther; 1993 Jul; 266(1):114-20. PubMed ID: 8331552 [TBL] [Abstract][Full Text] [Related]
57. Mechanism of decreased vascular reactivity to angiotensin II in conscious, potassium-deficient rats. Paller MS; Douglas JG; Linas SL J Clin Invest; 1984 Jan; 73(1):79-86. PubMed ID: 6690484 [TBL] [Abstract][Full Text] [Related]
58. Functional studies of nonpeptide angiotensin II receptor subtype-specific ligands: DuP 753 (AII-1) and PD123177 (AII-2). Wong PC; Hart SD; Zaspel AM; Chiu AT; Ardecky RJ; Smith RD; Timmermans PB J Pharmacol Exp Ther; 1990 Nov; 255(2):584-92. PubMed ID: 2243344 [TBL] [Abstract][Full Text] [Related]
59. Non-peptide angiotensin II receptor antagonists. II. Pharmacology of S-8308. Chiu AT; Carini DJ; Johnson AL; McCall DE; Price WA; Thoolen MJ; Wong PC; Taber RI; Timmermans PB Eur J Pharmacol; 1988 Nov; 157(1):13-21. PubMed ID: 3234494 [TBL] [Abstract][Full Text] [Related]
60. Angiotensin II receptors in the gonads. Aguilera G; Millan MA; Harwood JP Am J Hypertens; 1989 May; 2(5 Pt 1):395-402. PubMed ID: 2719823 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]